Growth Investment Hermes Pharma is actively expanding its manufacturing footprint with multi-million euro investments in specialist plants to scale production capacity and cost efficiency, signaling readiness for larger client programs and higher volume partnerships.

Oral Dosage Specialist As a leading expert in user-friendly oral dosage forms (effervescent, chewable, instant drinks, lozenges, orally disintegrating granules), Hermes Pharma can be a preferred contract development and manufacturing organization for brands seeking innovative dosage formats.

Global Collaboration With a history of partnering with healthcare companies worldwide and a sister OTC portfolio, Hermes Pharma offers end-to-end support from formulation to regulatory, enabling cross-border launches and expansion of existing product lines.

Technology Stack Signals Utilize Hermes Pharma’s tech footprint (CRM, marketing, analytics, and ERP tools) to tailor outreach, demonstrate value in digital-enabled operations, and propose integrated solutions that streamline development timelines and regulatory submissions.

Mid-market Focus Revenue positioning and employee size place Hermes Pharma in the mid-market segment, presenting opportunities for mid-sized brands or regional players seeking scale, reliable supply, and competitive manufacturing costs without tier-one pricing.